The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Chronotherapy

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Chronotherapy

 

High impact information on Chronotherapy

 

Chemical compound and disease context of Chronotherapy

 

Biological context of Chronotherapy

 

Associations of Chronotherapy with chemical compounds

  • CONCLUSION: The ORR achieved with intensified chronomodulated delivery of 5-FU/l-FA was nearly twice as high as that earlier obtained by our cooperative group using less intensive 5-FU/FA chronotherapy [15].
  • Chronotherapy of trichlormethiazide in hypertensive patients [16].
  • Once-daily evening administration of Uniphyl tablets: announcement of first available chronotherapy of nocturnal asthma [17].
  • Thirteen patients with nocturnal asthma were evaluated before and during tulobuterol patch chronotherapy, applied once daily in the evening for 6 consecutive days [18].
  • For each disorder, we present data addressing its pathophysiology and potential treatments, including the use of behavioral measures and chronotherapy, bright light treatment and pharmacological treatments such as melatonin [19].
 

Gene context of Chronotherapy

 

Analytical, diagnostic and therapeutic context of Chronotherapy

References

  1. Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. Sothern, R.B., Lévi, F., Haus, E., Halberg, F., Hrushesky, W.J. J. Natl. Cancer Inst. (1989) [Pubmed]
  2. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lévi, F., Zidani, R., Misset, J.L. Lancet (1997) [Pubmed]
  3. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination. Granda, T.G., Filipski, E., D'Attino, R.M., Vrignaud, P., Anjo, A., Bissery, M.C., Lévi, F. Cancer Res. (2001) [Pubmed]
  4. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer. Parulekar, W., de Marsh, R.W., Wong, R., Mendenhall, W., Davey, P., Zlotecki, R., Berry, S., Rout, W.R., Bjarnason, G.A. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  5. Pharmacology of cardiovascular chronotherapeutic agents. Smith, D.H. Am. J. Hypertens. (2001) [Pubmed]
  6. Time for chronotherapy? Clock genes dictate sensitivity to cyclophosphamide. Green, C.B. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  7. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. Storms, W.W. J. Allergy Clin. Immunol. (2004) [Pubmed]
  8. Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts. Blumenthal, R.D., Waskewich, C., Goldenberg, D.M., Lew, W., Flefleh, C., Burton, J. Clin. Cancer Res. (2001) [Pubmed]
  9. In vitro circadian ANP secretion by gene transferring cells encapsulated in polycaprolactone tubes: gene chronotherapy. Wang, Z., Chen, L., Wan, C., Qu, Y., Cornélissen, G., Halberg, F. Peptides (2004) [Pubmed]
  10. Chronotherapy of high-dose active vitamin D3 in haemodialysis patients with secondary hyperparathyroidsm: a repeated dosing study. Tsuruoka, S., Wakaumi, M., Sugimoto, K., Saito, T., Fujimura, A. British journal of clinical pharmacology. (2003) [Pubmed]
  11. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Smolensky, M.H., Portaluppi, F. Am. Heart J. (1999) [Pubmed]
  12. Cancer chronotherapy. Lévi, F. J. Pharm. Pharmacol. (1999) [Pubmed]
  13. Theophylline chronotherapy of nocturnal asthma using bathyphase of circadian rhythm in peak expiratory flow rate. Burioka, N., Sako, T., Tomita, K., Miyata, M., Suyama, H., Igishi, T., Shimizu, E. Biomed. Pharmacother. (2001) [Pubmed]
  14. Circadian rhythm sleep disorders in adolescents: clinical trials of combined treatments based on chronobiology. Okawa, M., Uchiyama, M., Ozaki, S., Shibui, K., Ichikawa, H. Psychiatry and clinical neurosciences. (1998) [Pubmed]
  15. Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer. Curé, H., Chevalier, V., Adenis, A., Tubiana-Mathieu, N., Niezgodzki, G., Kwiatkowski, F., Pezet, D., Perpoint, B., Coudert, B., Focan, C., Lévi, F., Chipponi, J., Chollet, P. J. Clin. Oncol. (2002) [Pubmed]
  16. Chronotherapy of trichlormethiazide in hypertensive patients. Fujimura, A., Ohashi, K., Ebihara, A. Journal of clinical pharmacology. (1991) [Pubmed]
  17. Once-daily evening administration of Uniphyl tablets: announcement of first available chronotherapy of nocturnal asthma. Goldenheim, P.D. Chronobiol. Int. (1989) [Pubmed]
  18. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy. Burioka, N., Miyata, M., Endo, M., Fukuoka, Y., Suyama, H., Nakazaki, H., Igawa, K., Shimizu, E. Chronobiol. Int. (2005) [Pubmed]
  19. Etiology and treatment of intrinsic circadian rhythm sleep disorders. Campbell, S.S., Murphy, P.J., van den Heuvel, C.J., Roberts, M.L., Stauble, T.N. Sleep medicine reviews. (1999) [Pubmed]
  20. Circadian telomerase activity and DNA synthesis for timing peptide administration. Qu, Y., Wang, Z., Huang, X., Wan, C., Yang, C.L., Liu, B., Cornelissen, G., Halberg, F. Peptides (2003) [Pubmed]
  21. Toward a chronotherapy of ovarian cancer with taxol. Part I: Basic background. Cornélissen, G., Halberg, E., Long, H.J., Prem, K., Bakken, E., Touitou, Y., Elg, S., Haus, E., Halberg, F. Chronobiologia. (1991) [Pubmed]
  22. Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study. Tampellini, M., Bitossi, R., Brizzi, M.P., Saini, A., Tucci, M., Alabiso, I., Dogliotti, L. Tumori. (2004) [Pubmed]
  23. Marker rhythmometry with macrophage-colony stimulating factor (M-CSF). Elg, S., Halberg, E., Ramakrishnan, S., Cornélissen, G., Haus, E., Nicolau, G., Carson, L., Twiggs, L., Long, H.J., Halberg, F. Chronobiologia. (1991) [Pubmed]
  24. Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS). Dagan, Y., Yovel, I., Hallis, D., Eisenstein, M., Raichik, I. Chronobiol. Int. (1998) [Pubmed]
  25. Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trial. Adler, S., Lang, S., Langenmayer, I., Eibl-Eibesfeldt, B., Rump, W., Emmerich, B., Hallek, M. Cancer (1994) [Pubmed]
  26. Circadian rhythmicity of plasma lipid peroxidation and antioxidants in oral squamous cell carcinoma. Manoharan, S., Baskar, A.A., Manivasagam, T., Subramanian, P. Singapore medical journal. (2005) [Pubmed]
 
WikiGenes - Universities